These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents. Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686 [TBL] [Abstract][Full Text] [Related]
5. GSH-resistant and highly cytoselective ruthenium(II)- Kar B; Das U; De S; Pete S; Sharma S A; Roy N; S K AK; Panda D; Paira P Dalton Trans; 2021 Aug; 50(30):10369-10373. PubMed ID: 34308466 [TBL] [Abstract][Full Text] [Related]
6. DNA targeting half sandwich Ru(II)- Mondal A; Sen U; Roy N; Muthukumar V; Sahoo SK; Bose B; Paira P Dalton Trans; 2021 Jan; 50(3):979-997. PubMed ID: 33355328 [TBL] [Abstract][Full Text] [Related]
7. Intracellular Localization Studies of the Luminescent Analogue of an Anticancer Ruthenium Iminophosphorane with High Efficacy in a Triple-Negative Breast Cancer Mouse Model. Miachin K; Del Solar V; El Khoury E; Nayeem N; Khrystenko A; Appelt P; Neary MC; Buccella D; Contel M Inorg Chem; 2021 Dec; 60(24):19152-19164. PubMed ID: 34846878 [TBL] [Abstract][Full Text] [Related]
8. Effect of an Imidazole-Containing Schiff Base of an Aromatic Sulfonamide on the Cytotoxic Efficacy of N,N-Coordinated Half-Sandwich Ruthenium(II) Maji M; Acharya S; Bhattacharya I; Gupta A; Mukherjee A Inorg Chem; 2021 Apr; 60(7):4744-4754. PubMed ID: 33760599 [TBL] [Abstract][Full Text] [Related]
9. Selective anticancer activities of ruthenium(II)-tetrazole complexes and their mechanistic insights. Sonkar C; Malviya N; Sinha N; Mukherjee A; Pakhira S; Mukhopadhyay S Biometals; 2021 Aug; 34(4):795-812. PubMed ID: 33900532 [TBL] [Abstract][Full Text] [Related]
10. Similarities and differences in d Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765 [TBL] [Abstract][Full Text] [Related]
11. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity. Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, interactions with 9-MeG and cytotoxic activity of heterobimetallic Ru Tsolis T; Nikolaou N; Ypsilantis K; Kougioumtzi A; Kordias D; Magklara A; Garoufis A J Inorg Biochem; 2021 Jun; 219():111435. PubMed ID: 33819801 [TBL] [Abstract][Full Text] [Related]
13. New organometallic ruthenium(ii) complexes with purine analogs - a wide perspective on their biological application. Fandzloch M; Jędrzejewski T; Dobrzańska L; Esteban-Parra GM; Wiśniewska J; Paneth A; Paneth P; Sitkowski J Dalton Trans; 2021 Apr; 50(16):5557-5573. PubMed ID: 33908935 [TBL] [Abstract][Full Text] [Related]
14. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
15. Promoting the Anticancer Activity with Multidentate Furan-2-Carboxamide Functionalized Aroyl Thiourea Chelation in Binuclear Half-Sandwich Ruthenium(II) Complexes. Thangavel SK; Mohamed Kasim MS; Rengan R Inorg Chem; 2024 Apr; 63(16):7520-7539. PubMed ID: 38590210 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, Characterization, and Cytotoxicity of Morpholine-Containing Ruthenium(II) Chatterjee R; Bhattacharya I; Roy S; Purkait K; Koley TS; Gupta A; Mukherjee A Inorg Chem; 2021 Aug; 60(16):12172-12185. PubMed ID: 34346215 [TBL] [Abstract][Full Text] [Related]
17. Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes. Ludwig G; Mojić M; Bulatović M; Mijatović S; Maksimović-Ivanić D; Steinborn D; Kaluđerović GN Anticancer Agents Med Chem; 2016; 16(11):1455-1460. PubMed ID: 26510901 [TBL] [Abstract][Full Text] [Related]
18. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding. Sangeetha S; Murali M Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196 [TBL] [Abstract][Full Text] [Related]